ET190L1-ARTEMIS™ T Cells in Relapsed, Refractory B Cell Leukemia and Lymphoma
Clinical trial NCT03895944 · UNKNOWN
Trial details
- NCT number
- NCT03895944
- Sponsor
- First Affiliated Hospital Xi'an Jiaotong University
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-06
- Primary completion
- 2019-12-06
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.